Company news

Nexalis Therapeutics Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Jun24 Quarterly Activities Report

July 31, 2024

Jun24 Appendix 4C Cash Flow Report

July 31, 2024

Mar24 Appendix 4C Cash Flow Report

April 30, 2024

Mar24 Quarterly Activities Report

April 30, 2024

Dec23 Quarterly Activities Report

January 16, 2024

Dec23 Appendix 4C Cash Flow Report

January 16, 2024

IRX211 - Targeted Pain Indication Nomination - BTcP

January 10, 2024

Significant Milestone - Completion of IRX211 Phase 1 Trial

December 3, 2023

Sep23 Quarterly Activities Report

October 31, 2023

Sep23 Appendix 4C

October 31, 2023

Quarterly Activities Report

July 30, 2023

Quarterly Appendix 4C Cash Flow Report

July 30, 2023

First Cohort Complete for Phase 1, Pain Indication IRX211

June 14, 2023

First Patient Dosed for Phase 1, Pain Indication IRX211

June 7, 2023

Ethics Approval for Phase 1 CRPS

March 20, 2023

Contract Research Organisation Appointment

December 21, 2022

Board and Management Changes

September 27, 2022

Private Placement to raise $1.2m

September 19, 2022

InhaleRx Ltd appoints Executive Director

December 28, 2021

Appendix 4C Cash Flow Report

October 31, 2021

Quarter 2 Update

July 28, 2021

Appendix 4C - quarterly

July 28, 2021

Quarter 1 Update

April 28, 2021

Quarter 4 Update

January 28, 2021

Placement of Rights Issue Shortfall

January 18, 2021

Rights Issue Offer Document

December 6, 2020

Non-renounceable rights issue

December 6, 2020

$720,500 Private Placement

November 4, 2020

Quarter 3 Update

October 20, 2020

Pause in Trading

October 19, 2020

CEO appointment

October 11, 2020

Reinstatement to Official Quotation

October 1, 2020

Private Placement and Market update

October 1, 2020

Voluntary Suspension

September 28, 2020

Private Placement Successfully Completed to raise $300,000

June 17, 2020

Licence Agreement with Jayex Healthcare

June 11, 2020

Response to ASX Price Query

March 27, 2020

Pause in trading

March 26, 2020

Private Placement Successfully Completed to raise $330,000

January 27, 2020

Production of new slim line Smart Vaporiser for usa

December 23, 2019

Lifespot signs Heads of agreement with IONIC brands

July 1, 2019

Business Development focus in rapid growth Cannabis Category

April 7, 2019

Amended - Appendix 4C September 2018 Quarter

January 31, 2019

Commercial Sales and Distribution Agreement with CBDS Health

December 18, 2018

First production completed for strong vape segment growth

December 12, 2018

LSH Acquires Seng Vital for Cannabis Opportunities

October 1, 2018

Lifespot Strengthens Go-To-Market Cannabis Strategy

September 18, 2018

Update on Unique Cannabis Vaporiser launch and Bodytel

August 16, 2018

LSH in discussions to finance integrated cannabis producers

June 19, 2018

B.Braun to launch Omnitest 5 BT with Body-Tel

June 4, 2018

← Newer news releases · Older news releases →

Decks

The 5 newest of 12 decks. Every deck is listed under its year.